Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05636215 |
Title | A First-in-human Study of IBI354 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Innovent Biologics (Suzhou) Co. Ltd. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Scientia Clinical Research Ltd | NOT_YET_RECRUITING | Randwick | New South Wales | 2031 | Australia | Details |
Sunshine Coast University Private Hospital | NOT_YET_RECRUITING | Sunshine Coast | Queensland | 4575 | Australia | Details |
Monash Health | NOT_YET_RECRUITING | Clayton | Victoria | 3168 | Australia | Details |
Peking University Cancer Hospital | RECRUITING | Beijing | Beijing | 100142 | China | Details |
Affiliated Cancer Hospital of Chongqing University | RECRUITING | Chongqing | Chongqing | 400030 | China | Details |